{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:08:45Z","timestamp":1780103325733,"version":"3.54.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.juro.2010.09.101","type":"journal-article","created":{"date-parts":[[2010,12,18]],"date-time":"2010-12-18T09:14:58Z","timestamp":1292663698000},"page":"483-488","source":"Crossref","is-referenced-by-count":15,"title":["The Prostate Cancer Risk Calculator From the Prostate Cancer Prevention Trial Underestimates the Risk of High Grade Cancer in Contemporary Referral Patients"],"prefix":"10.1097","volume":"185","author":[{"given":"Tin C.","family":"Ngo","sequence":"first","affiliation":[{"name":"Department of Urology and Health Research and Policy (BBT, PWL), Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brit B.","family":"Turnbull","sequence":"additional","affiliation":[{"name":"Department of Urology and Health Research and Policy (BBT, PWL), Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip W.","family":"Lavori","sequence":"additional","affiliation":[{"name":"Department of Urology and Health Research and Policy (BBT, PWL), Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Presti","sequence":"additional","affiliation":[{"name":"Department of Urology and Health Research and Policy (BBT, PWL), Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2010.09.101_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer Statisitics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.juro.2010.09.101_bib2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3322\/canjclin.35.1.36","article-title":"Probabilities of eventually developing or dying of cancer\u2014United States","volume":"35","author":"Seidzman Mushinski","year":"1985","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.juro.2010.09.101_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/archinte.166.1.38","article-title":"The effectiveness of screening for prostate cancer: a nested case-control study","volume":"166","author":"Concato","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.juro.2010.09.101_bib4","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2010.09.101_bib5","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schr\u00f6der","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2010.09.101_bib6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer","volume":"349","author":"Thomspon","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2010.09.101_bib7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/jnci\/djj131","article-title":"Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial","volume":"98","author":"Thompson","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2010.09.101_bib9","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.juro.2009.08.056","article-title":"Validation in a multiple urology practice cohort of the Prostate Cancer Prevention Trial calculator for predicting prostate cancer detection","volume":"182","author":"Eyre","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.09.101_bib10","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1464-410X.2008.08127.x","article-title":"Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone","volume":"103","author":"Hernandez","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2010.09.101_bib11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.juro.2009.10.007","article-title":"Performance of Prostate Cancer Prevention Trial risk calculator in a contemporary cohort screened for prostate cancer and diagnosed by extended prostate biopsy","volume":"183","author":"Nguyen","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.09.101_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0022-5347(05)64024-4","article-title":"Prostate biopsy: indications and technique","volume":"169","author":"Matlaga","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.09.101_bib13","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0090-4295(99)80353-7","article-title":"The influence of prostate size on cancer detection","volume":"46","author":"Uzzo","year":"1995","journal-title":"Urology"},{"key":"10.1016\/j.juro.2010.09.101_bib14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ijrobp.2003.10.014","article-title":"Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients","volume":"59","author":"King","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.juro.2010.09.101_bib15","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/jnci\/dji248","article-title":"Prostate cancer and the Will Rogers phenomenon","volume":"97","author":"Albertsen","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2010.09.101_bib16","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/pros.21084","article-title":"Common variants at 8q24 are associated with prostate cancer risk in Taiwanese men","volume":"80","author":"Chen","year":"2010","journal-title":"Prostate"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534710047592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534710047592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2010.09.101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T01:44:54Z","timestamp":1651196694000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2010.09.101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["10.1016\/j.juro.2010.09.101"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2010.09.101","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}